IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Thursday, 28 April 2016

AMD' s license deal in China: the start of something big?

›
The potential for a single technology license to change the fate of a public company is not a usual occurrence. For sure, there are compa...
Sunday, 24 April 2016

Can labor laws hollow-out software competencies: the case of Mercedes-Benz

›
The effect of legal provisions in enhancing or inhibiting innovation is often difficult to show. An interesting case where it may be able ...
Tuesday, 19 April 2016

Almost One Billion Dollar Verdict in U.S. Trade Secret Case

›
Wow!  That is quite a verdict.  A Wisconsin jury awarded $240 million in compensatory damages and $700 million in punitive damages for seven...
Tuesday, 12 April 2016

AIPLA 2016 U.S. Model Patent Jury Instructions Released

›
The American Intellectual Property Law Association (AIPLA) Patent Litigation Committee has released the AIPLA U.S. Model Patent Jury Instruc...

Georgetown Conference: Taxation of Intellectual Property in the Global Economy

›
On Friday, March 11, Georgetown University sponsored a conference titled, “Taxation of Intellectual Property in the Global Economy.”   A d...
Tuesday, 5 April 2016

Just Who is a Patent Troll? Ask VirnetX.

›
This blog recently reported on an East Texas jury awarding VirnetX over $600 million against Apple.   In a recent interesting article in Co...
1 comment:

Oxfirst Free Webinar: Determining the Value of a Patent

›
Our friend at Oxfirst , Roya Ghafele , has let us know about another timely webinar sponsored by Oxfirst.   Dr. Ednaldo Silva , Founder and ...
Thursday, 24 March 2016

Fawlty Towers - TV Format Licensing

›
This blogger has happy memories as a teenager of family TV viewing of the BBC comedy series Fawlty Towers . Even today his generation will...
Tuesday, 22 March 2016

The Pharmaceutical Pricing Problem: A Call to Exercise Bayh-Dole Act March-In Rights Heard?

›
The United States is struggling with the high cost of healthcare.   Notably, one cause of the high cost is the price of pharmaceuticals.  ...
‹
›
Home
View web version
Powered by Blogger.